Cover Image

INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS -SIMPLE SOLUTIONS

Show other versions (1)

Indications for myocardial cytoprotector, trimetazidine, in patients with ischemic heart disease are analyzed and justified according to evidence based medicine. Results of a multicenter randomized comparative KARDIOKANON study are discussed in terms of efficacy and tolerability of two variants of t...

Full description

Saved in:

Bibliographic Details
Main Author:	Zh. M. Sizova (Author)
Format:	Book
Published:	Столичная издательская компания, 2015-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS -SIMPLE SOLUTIONS
by: Zh. M. Sizova
Published: (2015)

PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
by: N. Yu. Karpova, et al.
Published: (2015)

PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
by: N. Yu. Karpova, et al.
Published: (2015)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015)

Respiratory tract infections in pediatrics: difficult answers to simple questions
by: I.V. Andreeva, et al.
Published: (2020)

Difficult questions of intravenous thrombolytic therapy in ischemic stroke
by: Aleksey A. Kulesh
Published: (2021)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016)

Myocardial Perfusion Scintigraphy in Ischemic Heart Disease
by: Sonia María Sánchez Valcarcel, et al.
Published: (2021)

Myocardial Perfusion Scintigraphy in Ischemic Heart Disease
by: Sonia María Sánchez Valcarcel, et al.
Published: (2021)

State stiffness parameters of the vascular wall in hypertensive patients complex therapy cytoprotector and sartans
by: V. P. Mikhin, et al.
Published: (2015)

Prognostic evaluation in patients with ischemic heart disease treatment with revascularization myocardial surgery
by: Mirtha López Ramírez, et al.
Published: (2015)

The Patient Encounter: Asking Difficult Questions
by: Kristin Hahn-Cover
Published: (2007)

THE INFLUENCE OF ADHERENCE TO TREATMENT ON MYOCARDIAL DYSFUNCTION IN ELDERLY AND SENILE PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
by: Iu. V. Nikishchenkova, et al.
Published: (2018)

Operability in transposition of great arteries with ventricular septal defect: A difficult question - is the answer really so simple?
by: Subramanyan Raghavan
Published: (2011)

Ethical, technological, and economic advantages of myocardial perfusion in ischemic heart disease
by: Aozi Feng, et al.
Published: (2017)

On the interchangeability of calcineurine inhibitors
by: K. E. Zatolochina, et al.
Published: (2018)

Features of myocardial deformation in patients with ischemic heart disease with moderate dilatation of cavity of the left ventricle complicated by the myocardial infarction
by: A. V. Molodan, et al.
Published: (2014)

Biomarkers of Myocardial Injury in Congenital Heart Disease: More Questions than Answers
by: Chun-An Chen
Published: (2016)

LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: A. S. Kerimkulova, et al.
Published: (2016)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015)

THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL
by: A. I. Malyhina, et al.
Published: (2015)

THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL
by: A. I. Malyhina, et al.
Published: (2015)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015)

Ischemic Heart Disease
Published: (2013)

Interchangeability among carbamazepine formulations: the impact over epilepsy patients
by: Virgínia Paula Frade, et al.
Published: (2022)

MUCOLYTICS FOR CHILDREN: DIFFICULT ISSUES, KEY SOLUTIONS
by: O. I. Simonova
Published: (2014)

Interchangeable drugs in Peru. A review study
by: Ericson Félix Castillo Saavedra, et al.
Published: (2023)

Peculiarities of approaches to assessing the interchangeability of antiepileptic drugs
by: E. O. Zhuravleva, et al.
Published: (2018)

Generic antihypertensive medications with therapeutic interchangeability requirements
by: Giulianna Gamero-Vega, et al.
Published: (2019)

Health behavior of patients with ischemic heart disease
by: Paweł Węgorowski, et al.
Published: (2017)

Health behavior of patients with ischemic heart disease
by: Paweł Węgorowski, et al.
Published: (2017)

CLINICAL CASE OF THROMBOLYTIC THERAPY OF RECURRENT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENT WITH LONG HISTORY OF ISCHEMIC HEART DISEASE
by: N. T. Vatutin, et al.
Published: (2016)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015)

Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin
by: A. N. Zakirova, et al.
Published: (2022)

Transforming Growth Factor β1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Genesis
by: N. E. Zakirova, et al.
Published: (2021)